Elevated list prices could restrict early access and overburden health systems, as cost becomes a salient concern for patients and providers alike
To address unmet needs in the treatment of type 2 diabetes in Korea, we have decided to initiate domestic supply prior to reimbursement approval, thereby expanding treatment options for healthcare providers and ensuring patients can fully benefit from the therapy." The official added, To further enhance patient access to treatment, we are in close consultation with relevant authorities with the goal of securing prompt national health insurance coverage approval for Ozempic. Eli Lilly's competing drug, Mounjaro (tirzepatide), is also currently undergoing review for national health insurance coverage for its type 2 diabetes indication
Douglas Dieterich, director of the Institute of Liver Medicine at Mount Sinai Health System Icahn School of Medicine in New York , was not affiliated with this study but commented on the findings
Pain scores improved by approximately 76% on the WOMAC scale, and more than 12% of Retatrutide-treated participants reported complete freedom from knee pain at week 68, compared to 4.2% on placebo
%20copy.jpg)
